Acadia Pharmaceuticals buy Royal Bank of Canada
Start price
07.08.24
/
50%
€13.87
Target price
07.08.25
€23.79
Performance (%)
0.00%
Price
07.08.24
€13.87
Summary
This prediction is currently active. Royal_Bank_of_Canada's BUY prediction for Acadia Pharmaceuticals is currently unchanged. This prediction currently runs until 07.08.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Acadia Pharmaceuticals | 0.00% |
iShares Core DAX® | -5.630% |
iShares Nasdaq 100 | -8.559% |
iShares Nikkei 225® | -9.576% |
iShares S&P 500 | -6.631% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its price target lowered by analysts at Royal Bank of Canada from $29.00 to $26.00. They now have an "outperform" rating on the stock.
Ratings data for ACAD provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€14.79
25.06.24
25.06.24
€27.09
25.06.25
25.06.25
-6.25%
07.08.24
07.08.24
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€22.00
28.02.24
28.02.24
€32.29
28.02.25
28.02.25
-36.98%
07.08.24
07.08.24
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€22.60
03.11.23
03.11.23
€30.73
03.11.24
03.11.24
-38.65%
07.08.24
07.08.24
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€29.00
14.07.23
14.07.23
€29.37
14.07.24
14.07.24
-44.09%
15.07.24
15.07.24